MENU

Upcoming ASX IPOs this week

Each week I like to look at the upcoming IPOs which are happening on the ASX. It gives me a chance to see if there are any future stars being listed and perhaps get in early on that success story.

Every single share that currently trades on the ASX was a newly-listed share at one point, they should not be avoided just because they are new.

A new float is usually when a private company is looking to sell a small or large portion of the business to new investors. The funds are typically needed for the growth of the business, such as buying property, funding product development or making an acquisition.

If any of the below shares sound interesting, you should read the prospectus to see if you want to invest.

According to ASX Ltd (ASX: ASX) these are some of the upcoming listings:

HeraMED Limited (ASX: HMD)

Its principal activity is the development, manufacture and distribution of fetal heart beat monitors and other pregnancy-related solutions.

It is developing connected pregnancy monitoring solutions for home use with continuous monitoring, which will hopefully lead to even better outcomes for mothers and babies.

It’s looking to raise $6 million at $0.20 per share and list on 4 December 2018.

Jobstore Group Ltd (ASX: JOB)

Its principal activity is providing recruitment and human capital management platforms.

It helps employers & recruiters to post jobs on multiple job sites, classified ads and social network sites with just one submission. It says it offers jobs in 10 countries and more than 30 cities.

It’s looking to raise $8 million at $0.20 per share and list on 5 December 2018.

Revasum Inc (ASX: RVS)

Its principal activity is designing, manufacturing and marketing a portfolio of semiconductor processing equipment.

It makes the equipment that is used to make microelectronics. Examples include the sensors, LEDs, RF devices and power devices consumed by the Internet of Things,  iPhones, fitbits, automotive, 5G and industrial applications.

It’s looking to raise $30.7 million at $2 per share and list on 4 December 2018.

Tymlez Group Limited (ASX: TYM)

Its principal activity is software development providing businesses with a scalable blockchain solution platform.

The company wants to help companies utilize emerging Blockchain technologies to create applications that will not only support new digital business models, but also integrate existing IT software.

It’s looking to raise $8 million at $0.22 per share and list on 7 December 2018.

Foolish takeaway

All of these businesses sound interesting but I’m not considering investing in any of them for my own portfolio.

They are outside my circle of competence, so I’m leaving them to be invested in by others. However, of the four, Revasum could be the one to watch.

Motley Fool contributor Tristan Harrison has no position in any of the stocks mentioned. The Motley Fool Australia owns shares of ASX Limited. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Scott Phillips.

The 5 mining stocks we’re recommending in 2019…

For decades, Australian mining companies have minted money for individual investors like you and me. But if you believe the pundits and talking heads on TV, those days are long gone. Finito! Behind us forever…

We say nothing could be further from the truth. To earn the really massive returns, you’ve got to fish where others aren’t fishing—and the mining sector could be primed for a resurgence. That’s why top Motley Fool analysts just revealed their exciting new research on 5 ASX miners they believe could help you profit in 2019 and beyond…

Including:

The best way we see to play the global zinc shortage… Our #1 favourite large-cap miner (hint: it’s not BHP)… one early-stage gold miner we think could hit the motherlode… Plus two more surprising companies you probably haven’t heard of yet!

For free access to our brand-new research, simply click here or the link below. But be warned, this research is available free for a limited time only, and we reserve the right to withdraw it at any time.

Click here for your FREE report!